33.96
price up icon0.77%   0.26
after-market アフターアワーズ: 34.11 0.15 +0.44%
loading
前日終値:
$33.70
開ける:
$33.83
24時間の取引高:
4.15M
Relative Volume:
0.75
時価総額:
$69.29B
収益:
$39.71B
当期純損益:
$3.17B
株価収益率:
9.8655
EPS:
3.4423
ネットキャッシュフロー:
$6.05B
1週間 パフォーマンス:
+1.83%
1か月 パフォーマンス:
-10.63%
6か月 パフォーマンス:
-25.82%
1年 パフォーマンス:
-3.52%
1日の値動き範囲:
Value
$33.76
$34.15
1週間の範囲:
Value
$33.17
$34.15
52週間の値動き範囲:
Value
$32.83
$45.92

Gsk Plc Adr Stock (GSK) Company Profile

Name
名前
Gsk Plc Adr
Name
セクター
Healthcare (1195)
Name
電話
-
Name
住所
-
Name
職員
70,200
Name
Twitter
@GSK
Name
次回の収益日
2024-10-30
Name
最新のSEC提出書
Name
GSK's Discussions on Twitter

GSK を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
GSK 33.96 69.29B 39.71B 3.17B 6.05B 3.4423
LLY 748.01 710.91B 40.86B 8.37B -2.28B 5.4193
NVO 105.06 466.80B 39.36B 13.79B 9.83B 2.4077
JNJ 155.17 353.35B 87.70B 14.68B 19.03B 13.47
ABBV 176.95 312.70B 55.53B 5.12B 15.62B 3.65
MRK 99.18 250.89B 63.17B 12.15B 14.84B 1.80

Gsk Plc Adr Stock (GSK) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-07-08 ダウングレード UBS Buy → Neutral
2024-05-30 開始されました Goldman Neutral
2024-03-04 アップグレード Guggenheim Neutral → Buy
2024-02-13 アップグレード Citigroup Neutral → Buy
2024-01-23 開始されました Morgan Stanley Equal-Weight
2024-01-16 再開されました UBS Buy
2024-01-03 アップグレード Jefferies Hold → Buy
2023-07-14 開始されました HSBC Securities Reduce
2023-03-17 アップグレード Deutsche Bank Hold → Buy
2023-02-27 再開されました Goldman Buy
2023-01-03 ダウングレード JP Morgan Neutral → Underweight
2022-12-05 ダウングレード BofA Securities Neutral → Underperform
2022-11-11 ダウングレード UBS Neutral → Sell
2022-09-15 アップグレード Credit Suisse Underperform → Neutral
2022-09-08 ダウングレード Jefferies Buy → Hold
2022-08-05 再開されました Morgan Stanley Equal-Weight
2022-07-21 再開されました Citigroup Neutral
2022-02-11 ダウングレード DZ Bank Buy → Hold
2021-11-05 アップグレード Barclays Underweight → Equal Weight
2021-06-24 アップグレード Deutsche Bank Sell → Hold
2021-03-23 ダウングレード SVB Leerink Outperform → Mkt Perform
2021-02-04 ダウングレード Deutsche Bank Hold → Sell
2021-01-20 ダウングレード Credit Suisse Neutral → Underperform
2021-01-15 開始されました Deutsche Bank Hold
2020-11-02 アップグレード Liberum Hold → Buy
2020-09-29 開始されました Berenberg Buy
2020-02-12 ダウングレード Shore Capital Hold → Sell
2020-01-16 ダウングレード Barclays Equal Weight → Underweight
2019-12-02 開始されました SVB Leerink Outperform
2019-11-21 アップグレード UBS Neutral → Buy
2019-10-11 アップグレード Cantor Fitzgerald Hold → Buy
2019-09-03 再開されました Citigroup Neutral
2019-09-03 アップグレード Societe Generale Sell → Buy
2019-08-13 再開されました JP Morgan Neutral
2019-06-17 再開されました Morgan Stanley Underweight
2019-03-08 ダウングレード Shore Capital Buy → Hold
2019-02-22 ダウングレード UBS Buy → Neutral
2019-01-14 ダウングレード Exane BNP Paribas Outperform → Neutral
2018-12-11 再開されました Jefferies Buy
2018-10-09 開始されました Guggenheim Neutral
2018-08-30 ダウングレード Liberum Buy → Hold
2018-04-04 アップグレード Exane BNP Paribas Neutral → Outperform
2018-03-22 アップグレード Morgan Stanley Underweight → Equal-Weight
2018-02-09 アップグレード Kepler Reduce → Hold
すべてを表示

Gsk Plc Adr (GSK) 最新ニュース

pulisher
Nov 19, 2024

GSK's Investigational Liver Disease Candidate Hits Primary Goal In Late-Stage Study To Treat Relentless Itch In Some Patients - Benzinga

Nov 19, 2024
pulisher
Nov 18, 2024

5 Stocks to Buy While They’re Still Cheap After Earnings - Morningstar

Nov 18, 2024
pulisher
Nov 13, 2024

Diabetes Care Nutrition Market Report 2024 with Forecasts to 2029 - GlobeNewswire Inc.

Nov 13, 2024
pulisher
Nov 12, 2024

The 10 Best Companies to Invest in Now - Morningstar

Nov 12, 2024
pulisher
Nov 04, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Nov 04, 2024
pulisher
Nov 04, 2024

The Best Defensive Stocks to Buy - Morningstar

Nov 04, 2024
pulisher
Nov 01, 2024

GSK Plc ADR (NYSE: GSK) Has Outstanding Potential - Stocks Register

Nov 01, 2024
pulisher
Oct 30, 2024

GSK (GSK) Q3 Earnings Surpass Estimates - Yahoo Finance

Oct 30, 2024
pulisher
Oct 29, 2024

What Do Analysts Think About ICICI Bank Ltd. ADR’s (NYSE:IBN) Future? - Stocks Register

Oct 29, 2024
pulisher
Oct 25, 2024

GSK Plc ADR (GSK): An Important Analyst Insights - Stocks Register

Oct 25, 2024
pulisher
Oct 21, 2024

5 Stocks to Buy if You’re Concerned About US Market Valuations - Morningstar

Oct 21, 2024
pulisher
Oct 18, 2024

21 Best Healthcare Companies to Invest In - Morningstar

Oct 18, 2024
pulisher
Oct 16, 2024

Current share price is - GSK

Oct 16, 2024
pulisher
Oct 15, 2024

D-Wave Quantum Inc (QBTS) rating initates by B. Riley Securities - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

GSK's Studies On Depemokimab For Nasal Polyps Meet Primary Goals - Barchart

Oct 15, 2024
pulisher
Oct 15, 2024

Ophthalmic Disease Therapeutics Market Analysis by Age-related Macular Degeneration, Diabetic Macular Edema, & Other Retinal Disorders - GlobeNewswire Inc.

Oct 15, 2024
pulisher
Oct 15, 2024

GSK Plc ADR [GSK] is 5.59% higher this YTD. Is it still time to buy? - The DBT News

Oct 15, 2024
pulisher
Oct 14, 2024

What You Didn’t Know About General Motors Company (NYSE: GM) This Week - Stocks Register

Oct 14, 2024
pulisher
Oct 14, 2024

GSK’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle

Oct 14, 2024
pulisher
Oct 14, 2024

Before You Invest, Make Sure You Check This ADT Inc (NYSE: ADT) Analysis - Stocks Register

Oct 14, 2024
pulisher
Oct 14, 2024

What Are You Thinking About Investing In Medical Properties Trust Inc (NYSE: MPW) Stock? - Stocks Register

Oct 14, 2024
pulisher
Oct 10, 2024

Why GSK Stock Rocketed Nearly 6% Skyward on Wednesday - sharewise

Oct 10, 2024
pulisher
Oct 10, 2024

Introducing Our Rant Against GSK Plc ADR - US Post News

Oct 10, 2024
pulisher
Oct 10, 2024

GSK Posts New Data From Phase III Study on RSV Vaccine Arexvy - Zacks Investment Research

Oct 10, 2024
pulisher
Oct 09, 2024

Balance Sheet Insights: GSK Plc ADR (GSK)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Oct 09, 2024
pulisher
Oct 09, 2024

Pilgrim’s Pride Corp. (PPC) receives an Equal-weight rating from Stephens - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

Berenberg upgrades Carnival plc ADR (CUK) stock to a Hold - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

JP Morgan analysts downgrades an Underweight rating for Organon & Co. (OGN) - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

GSK Plc ADR (GSK) gets rating Downgrade from UBS - Knox Daily

Oct 09, 2024
pulisher
Oct 08, 2024

GSK Plc ADR (GSK) Stock: A Comprehensive 52-Week Review - The InvestChronicle

Oct 08, 2024
pulisher
Oct 07, 2024

Precidian to List First ADRhedged Securities in the U.S. on Cboe - Traders Magazine

Oct 07, 2024
pulisher
Oct 07, 2024

Precidian to List First ADRhedged Securities in the U.S. on Cboe, Providing Exposure to Individual International Companies with an Embedded Currency Hedge - PR Newswire

Oct 07, 2024
pulisher
Oct 04, 2024

Tenet Healthcare Corp. [THC] stock for 1,879,734 USD was sold by Ramsey R. Scott - Knox Daily

Oct 04, 2024
pulisher
Oct 03, 2024

Ratio Analysis: Unpacking GSK Plc ADR (GSK)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Oct 03, 2024
pulisher
Oct 02, 2024

GSK Plc ADR [GSK] Insider Activity: An Update for Investors - Knox Daily

Oct 02, 2024
pulisher
Oct 02, 2024

GSK Plc ADR (GSK) Stock: Navigating a Year of Stock Volatility - The InvestChronicle

Oct 02, 2024
pulisher
Oct 02, 2024

Cantor Fitzgerald’s latest rating for AMGN stock - Knox Daily

Oct 02, 2024
pulisher
Sep 27, 2024

Nutanix Inc [NTNX] Chief Financial Officer makes an insider sale of 24,316 shares worth 1,430,939. - Knox Daily

Sep 27, 2024
pulisher
Sep 26, 2024

GSK’s Stock Market Adventure: 9.44% YTD Growth Amidst Volatility - The InvestChronicle

Sep 26, 2024
pulisher
Sep 26, 2024

GSK Shares Experience Decline in Value - Knox Daily

Sep 26, 2024
pulisher
Sep 26, 2024

The Best Healthcare Stocks to Buy - Morningstar

Sep 26, 2024

Gsk Plc Adr (GSK) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
drug_manufacturers_general BMY
$58.87
price up icon 1.10%
drug_manufacturers_general SNY
$48.28
price up icon 0.63%
drug_manufacturers_general PFE
$25.65
price up icon 2.07%
$294.53
price up icon 1.60%
drug_manufacturers_general NVS
$104.28
price up icon 0.41%
drug_manufacturers_general MRK
$99.18
price down icon 0.68%
大文字化:     |  ボリューム (24 時間):